2-107843634-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_182588.3(RGPD4):c.686G>A(p.Arg229Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182588.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 14286Hom.: 0 Cov.: 3 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000992 AC: 24AN: 241922Hom.: 2 Cov.: 0 AF XY: 0.0000867 AC XY: 11AN XY: 126844
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000210 AC: 3AN: 14286Hom.: 0 Cov.: 3 AF XY: 0.00 AC XY: 0AN XY: 6566
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.686G>A (p.R229Q) alteration is located in exon 6 (coding exon 6) of the RGPD4 gene. This alteration results from a G to A substitution at nucleotide position 686, causing the arginine (R) at amino acid position 229 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at